0.772
price down icon2.40%   -0.019
after-market Handel nachbörslich: .79 0.018 +2.33%
loading

Finanzdaten der Renovorx Inc-Aktie (RNXT)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
39.34%
2.476
1.777 2.983 3.375 3.261
Operating Income/Loss
39.34%
-2.476
-1.777 -2.983 -3.375 -3.261
Nonoperating Income/Loss
196.55%
1.40
-1.45 1.562 1.048 0.004
Income/Loss From Continuing Operations Before Tax
66.66%
-1.076
-3.227 -1.421 -2.327 -3.257
Income/Loss From Continuing Operations After Tax
66.66%
-1.076
-3.227 -1.421 -2.327 -3.257
Net Income/Loss
66.66%
-1.076
-3.227 -1.421 -2.327 -3.257
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
10,911%
14.95
0.1358 10.69 10.66 9.09
Diluted Average Shares
10,911%
14.95
0.1358 10.69 10.66 -0.7738
Basic Earnings Per Share
76.67%
-0.07
-0.30 -0.13 -0.22 -0.36
Diluted Earnings Per Share
76.67%
-0.07
-0.30 -0.13 -0.22 -0.35
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$18.81
price up icon 4.44%
$68.57
price up icon 5.80%
$31.95
price up icon 2.37%
$23.24
price up icon 15.33%
biotechnology ONC
$230.36
price up icon 10.59%
$96.52
price up icon 3.65%
Kapitalisierung:     |  Volumen (24h):